US Patent Issued to Progenics Pharmaceuticals, EXINI Diagnostics on Sept. 15 for "Systems and methods for AI-assisted analysis of primary tumor images for prediction of metastases" (American, Polish Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,737,884, issued on Sept. 15, was assigned to Progenics Pharmaceuticals Inc. (N. Billerica, Mass.) and EXINI Diagnostics AB (Lund, Sweden).

"Systems and methods for AI-assisted analysis of primary tumor images for prediction of metastases" was invented by Karl Vilhelm Sjostrand (Atlantic Highlands, N.J.) and Kamil Rzechowski (Warsaw, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Presented herein are systems and methods for the use of automatically-identified suspect regions (e.g., hotspots) within the prostate as imaged in one or more medical images (e.g., PET, CT, or PET/CT image(s)) to predict metastases (e.g., to predict whether localized dis...